title: [99mTc-ceftizoxime scintigraphy in normal rats and abscess induced rats].
abstract: This study aimed to investigate the biodistribution of the 99mTc-ceftizoxime in normal rats and in rats bearing septic and sterile induced abscess.
  
  
  METHODS
  Three groups of rats were studied. a) Six normal rats b) 15 rats with E. coli induced abscess and c) 15 rats with sterile zymosan induced abscess. Septic abscess was induced with 2 x 10(8) colony forming units of E. coli and sterile one with 0.1 mL of 5% sterile Zymosan. 24 h after the abscess induction, 12 MBq of 99mTc-CFT were injected iv. and whole body images were collected at 30 min, 1, 2, 4 and 6 h p.i. Areas of interest were drawn and lesion/background index was calculated. The 6 normal rats were scanned at the same times, killed at 6 h p.i and kidney, liver, spleen, lung, heart and muscle activity were measured. Each organ was weighed, cut and its activity measured. Parallelly, the biological activity of the labeled antibiotic and its binding to the E. coli and S. aureus bacteria were analyzed.
  
  
  RESULTS
  High biliary excretion was seen in all rats. Organ measurement showed the maximal uptake in kidney and very low uptake in muscles. Mean +/- s.d abscess/background ratio at 30 min, 1, 2, 4 and 6 h were 2.60 +/- 0.36, 2.67 +/- 0.66, 2.6 0 +/- 0.58, 2.78 +/- 0.84, 3.24 +/- 1.00 for septic abscess and 2.37 +/- 0.39, 2.10 +/- 0.38, 1.97 +/- 0.34, 1.82 +/- 0.25, 1.65 +/- 0.23 for aseptic abscess. The 99mTc-CFT uptake was significantly higher in the septic abscess than in sterile one (p < 0.05). The 99mTc-CFT uptake in the septic abscess remains stable or increases until along the 6 h. The 99mTc-CFT uptake in the aseptic abscess decreases along the time.
  
  
  CONCLUSIONS
  The scintigraphy with 99mTc-CFT seems able to differentiate sterile inflammation from infection. High biliary excretion limits its application in abdomen. Main application could be diagnosis of osteoarticular infection.
authors.affiliation: Hospital Universitario de Bellvitge-IDIBELL, Instituto de Ciencias e da Saúde, Departamento de Biofunção, Universidade Federal da Bahia, Brazil.
authors.forename: V
authors.initials: V
authors.lastname: Gomes Barreto
authors.forename: G
authors.initials: G
authors.lastname: Rabiller
authors.forename: F
authors.initials: F
authors.lastname: Iglesias
authors.forename: V
authors.initials: V
authors.lastname: Soroa
authors.forename: F
authors.initials: F
authors.lastname: Tubau
authors.forename: M
authors.initials: M
authors.lastname: Roca
authors.forename: J
authors.initials: J
authors.lastname: Martín-Comín
mesh_terms: D000038:Abscess / Q000000981:diagnostic imaging* / Q000382:microbiology; D000818:Animals; D015296:Ceftizoxime / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D003937:Diagnosis, Differential; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C510184:technetium 99m ceftizoxime; D015296:Ceftizoxime